Medco hires FDA genomics expert
Executive Summary
Felix Frueh joins Medco as VP-R&D, personalized medicine. He had been associate director for genomics in the FDA's Office of Clinical Pharmacology since 2004. While at the agency, Frueh was responsible for developing policy on pharmacogenomics. He also chaired FDA's Interdisciplinary Pharmacogenomics Review Group. In the new position at Medco, he will advance research in genetic testing aimed at improving the precision of pharmacy care and will develop the firm's Personalized Medicine Research Center, under construction in Whitestown, Ind. Medco currently is collaborating with the Mayo Clinic and Lab Corp. on genetic research on improving treatment with warfarin and tamoxifen (1"The Pink Sheet," Nov. 26, 2007, p. 11)